Glutathione reverses endothelial dysfunction and improves nitric oxide bioavailability
Abhiram Prasad, MBBS, MRCPa,
Neil P. Andrews, MBBS, MRCPa,
Feroz A. Padder, MBBSa,
Mohsin Husain, BSa and
Arshed A. Quyyumi, MD, MRCP, FACCa
a Cardiology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA

View larger version (22K):
[in a new window]
|
Figure 1 Protocol design. IA = intra-arterially; IV = intravenously; D5W = 5% dextrose.
|
|

View larger version (17K):
[in a new window]
|
Figure 2 Effects of acetylcholine on femoral blood flow velocity and femoral vascular resistance index, before and after glutathione. Data represent mean ± SEM; p values represent results of two-way analysis of variance.
|
|

View larger version (23K):
[in a new window]
|
Figure 3 Effects of acetylcholine on flow velocity and femoral vascular resistance index in patients with normal (left) and depressed (right) endothelial function, before and after glutathione. Data represent mean ± SEM; p values represent results of two-way analysis of variance.
|
|

View larger version (16K):
[in a new window]
|
Figure 4 Effects of nitroglycerin (NTG) and sodium nitroprusside on femoral blood flow velocity and femoral vascular resistance index, before and after glutathione. Data represent mean ± SEM.
|
|
|